Search
Search Results
##search.searchResults.foundPlural##
-
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1475PDF: 912HTML: 214 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3091PDF: 1131HTML: 381 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2623PDF: 953HTML: 4693 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3514PDF: 1346HTML: 3698Letter to Editor: 174 -
AN OBSERVATIONAL STUDY OF THE EFFECT OF HEMOGLOBINOPATHY, ALPHA THALASSEMIA AND HEMOGLOBIN E ON P. VIVAX PARASITEMIA
2734PDF: 866HTML: 367Distribution of malaria patient cohort along Thailand and borders during 2011-2012: 184 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1722PDF: 1052HTML: 238 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1936PDF: 1083HTML: 596 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2371PDF: 1192HTML: 3588Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 398 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4038PDF: 1213HTML: 1946Table 1: 181 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1358PDF: 787HTML: 299 -
PREVALENCE OF ALPHA THALASSEMIA IN MICROCYTIC ANEMIA: A TERTIARY CARE EXPERIENCE FROM NORTH INDIA
2374PDF: 1213HTML: 4666table: 194fig 1: 205fig 2: 163 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
951PDF: 515HTML: 7802 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4737PDF: 1733HTML: 2692Untitled: 199 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3114PDF: 1558HTML: 252 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3338PDF: 1272HTML: 1853Fig.1: 187Fig. 2: 194 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1335HTML: 379PDF: 805 -
MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS
1478PDF: 870HTML: 1416Table: 180 -
EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly
1506PDF: 486HTML: 218 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5093PDF: 1305HTML: 2732Cover letter: 181 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3246PDF: 1323HTML: 2618 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3198PDF: 1215HTML: 8094 -
Parasitic hypereosinophilia in childhood: a diagnostic challenge
2519PDF: 794HTML: 274Figure 1: 155 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1525PDF: 867HTML: 971figures: 165table 1: 171table2: 168table3: 169 -
Acquired Hemophilia A successfully treated with rituximab
1901PDF: 1125HTML: 1448Figure 1: 161 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1927PDF: 697HTML: 672Table1: patient's characteristics: 143Table 2: profile of each patient: 168 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1257PDF: 995HTML: 111 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1228PDF: 709HTML: 303 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1724PDF: 677HTML: 322 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3484PDF: 2373HTML: 1433







